Open3.370 | Close- |
Vol / Avg.11.384K / 46.488K | Mkt Cap104.395M |
Day Range3.250 - 3.430 | 52 Wk Range2.750 - 6.450 |
Anixa Biosciences Stock (NASDAQ: ANIX) stock price, news, charts, stock research, profile.
Open3.370 | Close- |
Vol / Avg.11.384K / 46.488K | Mkt Cap104.395M |
Day Range3.250 - 3.430 | 52 Wk Range2.750 - 6.450 |
Q4 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED) | ||||||
REV |
Q3 2023 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.090 | -0.080 | 0.0100 | ||||
REV | 0 | 0 | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|---|---|---|---|---|---|---|
2023-09-18 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 12.00 |
2023-08-29 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 12.00 |
2023-07-28 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 12.00 |
2023-07-12 | HC Wainwright & Co. | Yi Chen | Reiterates | BuyBuy | Maintains | - | 12.00 |
Ticker | Company | Chg % | Mkt Cap |
---|---|---|---|
ANIX | Anixa Biosciences | 0.6% | 104.4M |
VAXX | Vaxxinity | -1.72% | 105.7M |
CTMX | CytomX Therapeutics | 1.8% | 94.8M |
CARM | CARISMA Therapeutics | -1.67% | 95.2M |
ATOS | Atossa Therapeutics | -0.77% | 92.4M |
You can purchase shares of Anixa Biosciences (NASDAQ: ANIX) through any online brokerage.
Other companies in Anixa Biosciences’s space includes: Vaxxinity (NASDAQ:VAXX), CytomX Therapeutics (NASDAQ:CTMX), CARISMA Therapeutics (NASDAQ:CARM), Atossa Therapeutics (NASDAQ:ATOS) and Barinthus Biotherapeutics (NASDAQ:BRNS).
The latest price target for Anixa Biosciences (NASDAQ: ANIX) was reported by HC Wainwright & Co. on Monday, September 18, 2023. The analyst firm set a price target for 12.00 expecting ANIX to rise to within 12 months (a possible 257.14% upside). 12 analyst firms have reported ratings in the last year.
The stock price for Anixa Biosciences (NASDAQ: ANIX) is $3.36 last updated Today at December 1, 2023 at 4:37 PM UTC.
There is no dividend information for Anixa Biosciences.
Anixa Biosciences’s Q4 earnings are confirmed for Wednesday, January 3, 2024.
There is no upcoming split for Anixa Biosciences.
Anixa Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.